Use of diagnosis codes and/or wound culture results for surveillance of surgical site infection after mastectomy and breast reconstruction by Olsen, Margaret A & Fraser, Victoria J
Washington University School of Medicine
Digital Commons@Becker
Infectious Diseases Faculty Publications Infectious Diseases
5-2010
Use of diagnosis codes and/or wound culture
results for surveillance of surgical site infection after
mastectomy and breast reconstruction
Margaret A. Olsen
Washington University School of Medicine in St. Louis
Victoria J. Fraser
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/id_facpubs
Part of the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by the Infectious Diseases at Digital Commons@Becker. It has been accepted for inclusion in
Infectious Diseases Faculty Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact
engeszer@wustl.edu.
Recommended Citation
Olsen, Margaret A. and Fraser, Victoria J., "Use of diagnosis codes and/or wound culture results for surveillance of surgical site
infection after mastectomy and breast reconstruction" (2010). Infectious Diseases Faculty Publications. Paper 6.
http://digitalcommons.wustl.edu/id_facpubs/6
infection control and hospital epidemiology may 2010, vol. 31, no. 5
c o n c i s e c o m m u n i c a t i o n
Use of Diagnosis Codes and/or Wound
Culture Results for Surveillance
of Surgical Site Infection after Mastectomy
and Breast Reconstruction
Margaret A. Olsen, PhD, MPH; Victoria J. Fraser, MD
We compared surveillance of surgical site infection (SSI) after major
breast surgery by using a combination of International Classification
of Diseases, Ninth Revision, Clinical Modification diagnosis codes and
microbiology-based surveillance. The sensitivity of the coding al-
gorithm for identification of SSI was 87.5%, and the sensitivity of
wound culture for identification of SSI was 78.1%. Our results sug-
gest that SSI surveillance can be reliably performed using claims
data.
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Administrative claims data are increasingly being used for
surveillance of hospital-acquired infections, because the data
are easily accessible, are complete for virtually all patients, and
facilitate comparisons across institutions. The major problem
with the use of administrative data for surveillance is the un-
certain accuracy of the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis
codes for infectious complications. In the case of surgical site
infections (SSIs), the accuracy of ICD-9-CM procedure codes
to identify specific types of surgical procedures is also important
for reliably establishing specific surgical procedure SSI rates.
We previously performed a retrospective case-control study
of SSI after major breast surgery.1 We used data from this
study to determine the efficacy of using ICD-9-CM diagnosis
codes to identify SSI, compared with surveillance based on
microbiologic culture results.
methods
The case-control study was nested in a cohort of patients who
underwent a mastectomy or breast reconstructive surgery
(ICD-9-CM procedure codes 85.41–85.48, 85.53, 85.54, 85.7,
85.85, and 85.95) at Barnes-Jewish Hospital (a 1,251-bed,
tertiary care hospital affiliated with Washington University
School of Medicine) during the period from January 1, 1998,
through June 30, 2002, as described elsewhere.1,2 Potential
cases of SSI were identified by use of ICD-9-CM diagnosis
codes consistent with SSI and/or by use of wound cultures
performed during hospitalization or during rehospitalization
within 180 days after surgery (for inpatient or outpatient
surgical care or emergency department care). The ICD-9-CM
diagnosis codes included specific SSI codes (ie, 998.5, 998.51,
and 998.59) and infection codes unique to breast surgery
(996.69, infection and inflammatory reaction due to breast
prosthesis; 611.0, inflammatory disease of breast; 682.2, cel-
lulitis of the trunk; and 682.3, cellulitis of the axillae). All
administrative and microbiology data were obtained from the
Barnes-Jewish Hospital Medical Informatics database. The
relevant medical records were reviewed for all patients with
positive wound culture result(s) or ICD-9-CM diagnosis
code(s) suggestive of SSI, to determine signs and symptoms
of SSI. The gold standard for detection of SSI was a complete
review of the medical records, including microbiology and
pharmacy data, to identify cases of SSI meeting the criteria
provided by the Centers for Disease Control and Prevention’s
National Healthcare Safety Network.3
The sensitivity, specificity, positive predictive value (PPV),
and likelihood ratio were calculated for the SSI diagnosis code
algorithm and the wound culture SSI algorithm, and for the
surgical procedure codes for each type of breast surgical pro-
cedure. All data management and analyses were done with
the use of SPSS, version 15.0 (SPSS). Approval for the study
was obtained from our hospital’s Human Studies Committee.
results
During the 4.5-year study period, 1,200 surgical procedures
were given a code or codes for mastectomy and breast re-
construction during hospitalization. Of the 280 patients in
the nested case-control study, 236 (84.3%) underwent a mas-
tectomy that was coded; however, after a review of the medical
records, it was determined that 239 patients (85.4%) had
actually undergone a mastectomy (sensitivity, 98.7%; PPV,
100%). Seventy-eight (27.8%) of the 280 patients had un-
dergone a breast implant insertion that was correctly coded
during hospitalization (sensitivity, 100%; PPV, 100%). Sev-
enty patients (25.0%) underwent a procedure that was given
the code for transverse rectus abdominus myocutaneous flap
reconstruction; however, only 67 (23.9%) patients actually
underwent the procedure (sensitivity, 100%; PPV, 95.7%).
Twelve patients (4.3%) underwent a latissimus dorsi flap re-
construction that was correctly coded; however, another 4
patients (1.4%) underwent a latissimus dorsi flap reconstruc-
tion that was not given the correct ICD-9-CM procedure code
(sensitivity, 75%; PPV, 100%).
Ninety hospital admissions within 180 days after surgery
in 73 patients met the coding and/or microbiologic criteria
for potential SSI. Surgical admissions in 2 additional patients
were given an admitting ICD-9-CM diagnosis code that was
consistent with SSI; these 2 cases were excluded, because the
surgical procedures were performed on patients with a pre-
existing SSI.
The number of patients with an SSI that was identified by
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table 1. Comparison of the Use of Diagnosis Codes
and the Use of Positive Wound Culture Results to Iden-
tify Surgical Site Infection (SSI) within 180 Days after











Not identified 8 1,128
Wound culture
Identified 50 4
Not identified 14 1,132
note. The sensitivity of the coding algorithm for identi-
fication of SSI was 87.5% (positive predictive value, 87.5%),
and the sensitivity of wound culture for identification of SSI
was 78.1% (positive predictive value, 92.6%). ICD-9-CM, In-
ternational Classification of Diseases, Ninth Revision, Clinical
Modification.










True SSI attributable to other surgical procedure 2 Yes Yes
Infection attributed to adjuvant radiation therapy 1 Yes Yes
Noninfectious wound complication 1 Yes Yesa
Noninfectious wound complication 4 Yes No
Central venous catheter–related infection 2 Yes No
True SSI attributable to other surgical procedure 1 Yes No
Noninfectious wound complication 2 No Yesa
note. ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
a Cultures positive for rare skin flora with no other indications of SSI.
use of ICD-9-CM diagnosis code(s) and/or wound culture(s)
is shown in Table 1. The sensitivity of the coding algorithm
for identification of SSI was 87.5%, and the sensitivity of
wound culture for identification of SSI was 78.1%. Of the 64
patients with SSI, 42 (65.6%) were identified by use of both
ICD-9-CM diagnosis code(s) and wound culture(s), 14 (21.9%)
were identified by use of ICD-9-CM diagnosis code(s) only,
and 8 (12.5%) were identified by use of wound culture(s) only.
The specificity of the coding algorithm for identification of SSI
was 99.3%, and the specificity of wound culture for identifi-
cation of SSI was 99.6%. The positive likelihood ratio was 125
for the coding algorithm and 195 for wound culture, whereas
the negative likelihood ratio was 0.126 for the coding algorithm
and 0.220 for the wound culture surveillance method.
Table 2 lists the reasons for miscoding in 13 patients during
hospitalization. Two of the 6 patients with positive wound
culture results developed an SSI after a subsequent breast
surgery, and another patient developed an SSI after adjuvant
radiation therapy. Three of the 6 patients identified in error
by a positive wound culture result had only rare skin flora
isolated in the wound culture and no other indications of
SSI. Three of the 7 patients identified in error by the diagnosis
code algorithm without positive wound culture results de-
veloped either an SSI after another surgical procedure or a
central venous catheter–related infection. The diagnosis in
the remaining patients identified in error by the diagnosis
code algorithm was noninfectious wound complication (he-
matoma, fat necrosis, epidermolysis, or dehiscence), which
was made by their surgeon, without signs or symptoms of
SSI.
Of the 90 hospital admissions with an indication of SSI,
79 admissions were given ICD-9-CM diagnosis codes con-
sistent with SSI, and patients in 59 admissions had positive
wound culture results from tissue samples obtained from the
breast or donor site (for patients with autologous flap re-
construction). Patients in 77 of the 90 admissions that met
the coding or wound culture algorithm for SSI had an in-
fection that met the criteria for SSI provided by the Centers
for Disease Control and Prevention’s National Healthcare
Safety Network. For these 77 admissions in which the patient
had a confirmed SSI, patients in 44 admissions (57.1%) had
positive wound culture results, and the admission was given
an ICD-9-CM diagnosis code suggestive of SSI; 24 admissions
(31.2%) were given only an ICD-9-CM diagnosis code sug-
gestive of SSI; and patients in 9 admissions (11.7%) had a
positive wound culture result, but the admission was not
given an ICD-9-CM diagnosis code suggestive of SSI.
discussion
We found that surveillance of SSI after mastectomy and
breast reconstruction by using ICD-9-CM diagnosis codes
was highly sensitive and had a high PPV, compared with
surveillance of SSI by using microbiology data. This high
sensitivity may be due in part to the use of an expanded
group of ICD-9-CM codes as SSI indicators, including both
specific codes for SSI and infection codes unique to breast
surgery. Our results suggest that a combination of operation-
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specific ICD-9-CM diagnosis codes can be used with a high
degree of accuracy to perform SSI surveillance.
We also found that the coding of breast surgeries resulted
in a high degree of accuracy to perform SSI surveillance, with
the exception of the sensitivity for latissimus dorsi flap re-
construction. The sensitivity of ICD-9-CM procedure codes
for identification of mastectomy was previously reported to
be 100%, with a PPV of 94%.4 To our knowledge, our study
is the first to compute estimates for the PPVs of ICD-9-CM
procedure codes for breast reconstruction procedures. De-
termining the validity of coding of individual operative pro-
cedures is important for investigators using administrative
data to study variation in SSI rates after individual surgical
procedures.
Undercoding of infections, which results in low sensitivity,
is thought to be the major deterrent to use of ICD-9-CM
diagnosis coding algorithms to identify SSI. To compensate
for the potential for low sensitivity, some investigators have
used a very comprehensive list of ICD-9-CM diagnosis codes
to perform surveillance for SSI. Sherman et al5 and Stevenson
et al6 included diagnosis codes for a number of potentially
noninfectious wound complications (eg, dehiscence, non-
healing wound, postoperative fistula, and open wound) and
infections unlikely to be associated with SSI (eg, cryptococcal
and trypanosomiasis meningitis) to identify SSI after 9 dif-
ferent surgical procedures. Not surprisingly, the PPVs of the
combination of codes used for identification of SSI were low
in both studies.
In contrast, other studies have used a more restricted set
of ICD-9-CM diagnosis codes to identify SSI, primarily 998.5,
995.51, and 998.59 (postoperative infection).7-9 Best et al7 used
the 998.5 code to identify SSI after major noncardiac oper-
ations in the Department of Veterans Affairs National Surgical
Quality Improvement Program database. This single code had
a sensitivity of 21.3% and a PPV of 34.7%, compared with
the sensitivity of SSI surveillance performed by trained sur-
gical nurses. In a small study, Hebden and Roghmann9 found
that the 998.5 code was 100% sensitive and had a PPV of
62% to identify sternal SSI after coronary artery bypass sur-
gery. In the multicenter study by Yokoe et al,8 the sensitivity
of using the 998.5, 998.51, and 998.59 codes to identify SSI,
compared with the sensitivity of using routine infection con-
trol surveillance, was 54%–61% after coronary artery bypass
surgery and 50%–70% after breast operations, with PPVs
ranging from 58% to 86%.
Additional diagnosis codes have been used to tailor SSI
surveillance to individual surgical procedures, including the
use of code 996.6 to identify SSI after knee and hip arthros-
copy,10-12 and the use of codes 670 and 674.3 to identify en-
dometritis and SSI after cesarean section.8,13 The use of these
codes in combination with code 998.5 to identify SSI resulted
in a sensitivity of 88%–89% after total joint replacement sur-
gery10-12 and 48%–89% after cesarean section.8,13
There are some limitations to our study. Complete review
of the medical record to identify SSI on the basis of definitions
provided by the Centers for Disease Control and Prevention’s
National Healthcare Safety Network was performed only for
individuals whose case of infection was identified by use of
ICD-9-CM diagnosis codes consistent with SSI and/or by use
of wound culture, as well as a random subset of control patients
who showed no indications of infection. Thus, our calculations
of the sensitivity and specificity of the coding algorithm and
wound culture surveillance method assume that no additional
infections would have been identified in the remaining pop-
ulation without medical record review. In addition, our sur-
veillance methods would not have identified individuals with
SSI who were seen in follow-up at another institution or in-
dividuals in whom SSI was diagnosed in outpatient clinics, if
cultures were not obtained and the visits were not coded for
SSI. Thus, our methods likely underestimate the incidence of
superficial incisional SSI diagnosed in outpatient settings and
treated empirically with oral antibiotics. It would be prohibi-
tively expensive to perform postdischarge surveillance for these
cases, because identification of these infections would require
manual review of all clinic records.
The relatively small sample size resulted in a low preva-
lence of some operations, making it difficult to estimate the
accuracy of coding for these procedures. Barnes-Jewish Hos-
pital is a tertiary care hospital with a large referral population
of patients who underwent breast surgery, and our hospital
coders may be more familiar with their care and treatment
than are coders at small hospitals or institutions with fewer
breast surgeries. Despite these limitations, our results sug-
gest that administrative data can be reliably used to perform
surveillance for SSIs after some types of surgical procedures.
Our results also suggest that a combination of microbiology
and administrative data can improve the sensitivity of SSI
surveillance.
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